← back to search

Xiaojun Jing

Beijing University of Posts and Telecommunications · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Prostate Cancer Treatment and Research, Cancer-related molecular mechanisms research, Cancer-related gene regulation, and Epigenetics and DNA Methylation.
h-index
29
citations
11,293
works
59
NIH funding
primary concept
Biology
email

Recent publications

Comprehensive proteogenomic characterization of rare kidney tumors
Cell Reports Medicine 2024cited by 44position: middledoi
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Cancer Cell 2022cited by 202position: middledoi
Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy
Journal of Clinical Investigation 2020cited by 198position: middledoi
Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma
Neoplasia 2019cited by 13position: middledoi
Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate Cancer
Cancer Research 2018cited by 58position: middledoi
Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer
Cancer Cell 2017cited by 101position: middledoi
miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression
Molecular Cancer Research 2017cited by 61position: middledoi
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer
Neoplasia 2016cited by 96position: middledoi
MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer
Oncogene 2016cited by 70position: middledoi
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Nature 2014cited by 949position: middledoi
The lncRNA <i>PCAT29</i> Inhibits Oncogenic Phenotypes in Prostate Cancer
Molecular Cancer Research 2014cited by 133position: middledoi
The miR-124-Prolyl Hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression
Oncotarget 2014cited by 97position: middledoi
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
Nature Genetics 2013cited by 680position: middledoi
The mutational landscape of lethal castration-resistant prostate cancer
Nature 2012cited by 2,579position: middledoi
Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression
Neoplasia 2012cited by 114position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Arul M. Chinnaiyan · BioSurfaces (United States)10 papers (2014–2020)Marcin Cieślik · Icahn School of Medicine at Mount Sinai7 papers (2014–2020)Xuhong Cao · Howard Hughes Medical Institute6 papers (2014–2019)Balabhadrapatruni V. S. K. Chakravarthi · University of Alabama at Birmingham5 papers (2012–2017)Sooryanarayana Varambally · University of Alabama at Birmingham5 papers (2012–2017)Irfan A. Asangani · Science History Institute5 papers (2012–2017)Rohit Malik · Barts Health NHS Trust4 papers (2014–2019)Javed Siddiqui · University of Michigan4 papers (2012–2016)Jean C. Tien · Houston Methodist3 papers (2017–2019)Felix Y. Feng · Polytechnique Montréal3 papers (2014–2016)Kristin Juckette · University of Michigan–Ann Arbor3 papers (2017–2019)Heng Zheng · University of Michigan–Ann Arbor3 papers (2012–2018)Nallasivam Palanisamy · Henry Ford Health System3 papers (2012–2016)Satya S. Pathi · University of Michigan3 papers (2014–2017)Shaomeng Wang · Rogers (United States)3 papers (2014–2019)Moloy T. Goswami · University of Michigan–Ann Arbor3 papers (2014–2017)Saravana M. Dhanasekaran · Prince Sattam Bin Abdulaziz University3 papers (2012–2016)Xiaoju Wang · Michigan Center for Translational Pathology3 papers (2014–2018)Lakshmi P. Kunju · University of Michigan3 papers (2012–2016)Yuanyuan Qiao · University of Michigan–Ann Arbor2 papers (2017–2018)